The missing pieces are big: no human dosing, no human pharmacokinetics, no controlled human safety data, and no long-term outcome data in any species
Given the altered GI environment in GLP-1 users, documented protection through point-of-consumption is a more credible starting point than an unstated assumption of survivability
Low HDL (Good) Cholesterol There are no drugs approved to specifically raise HDL levels, but some treatments to lower triglycerides (fibrates, niacin) or LDL cholesterol (certain statins) can help increase levels of this healthy substance
Look for bars with 15g+ clean protein, no sugar alcohols (erythritol, maltitol), no fiber additives (chicory root, IMO), and short ingredient lists
GLP-1 is released in the gut when food is consumed
Changes in hormone levels, blood parameters, or metabolic markers can indicate prohibited substance use even without detecting the substance directly